Burning mouth syndrome
Conditions
Interventions
Aconinsan group(32 people administerd Aconinsan 9T/day for 3months)
Amitriptyline group(32 people administerd Amitriptyline 10-150/day for 3months)
Sponsors
Saga University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Patient diagnosed BMS 2)Patient aged from 20 to 90years old 3)Patient agreed this trial in writing
Exclusion criteria
Exclusion criteria: 1)Patient suffer from Angle-closure Glaucoma 2)Patient have medical history of hypersensivity to prescription drug 3)Patient have medical history of cardiovascular disease and cerebrovascular disorder 4)Patient suffer from prostate disease 5)Patient who administered MAOI 6)Patient suffer from hyperthyroidism 7)Patient suffer from convulsive disorder 8)Patient suffer from manic depression 9)Patients with organic brain disorders or predisposition to schizophrenia 10)Patients who have or have had suicidal thoughts or suicide attempts 11)Patients taking other antidepressants, anti-epileptic drugs, anti-anxiety drugs, etc. 12)Patient who is judged inappropriate by doctor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of pain improvement by VAS after 3 months of treatment | — |
Countries
Japan
Contacts
Public ContactKeisuke MORI
Saga University Hospital Department of oral and maxillofacial surgery
Outcome results
None listed